共 162 条
- [1] Burisch J(2020)Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study Lancet Gastroenterol Hepatol. 5 454-464
- [2] Vardi H(2014)Immunopathology of inflammatory bowel disease World J Gastroenterol. 20 6-21
- [3] Schwartz D(2008)Limited effects of dietary curcumin on Th-1 driven colitis in IL-10 deficient mice suggest an IL-10-dependent mechanism of protection Am J Physiol Gastrointest Liver Physiol. 295 G1079-1091
- [4] Wallace KL(2009)CD4 T-cell differentiation and inflammatory bowel disease Trends Mol Med. 15 199-207
- [5] Zheng LB(2014)Th1/Th2 cell's function in immune system Adv Exp Med Biol. 841 45-65
- [6] Kanazawa Y(1994)Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells Immunity. 1 553-562
- [7] Shih DQ(2003)Upregulation of interleukin-12 and -17 in active inflammatory bowel disease Scand J Gastroenterol. 38 180-185
- [8] Larmonier CB(2009)RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F Gastroenterology. 136 257-267
- [9] Uno JK(2020)MicroRNA-219a-5p suppresses intestinal inflammation through inhibiting Th1/Th17-mediated immune responses in inflammatory bowel disease Mucosal Immunol. 13 303-312
- [10] Lee KM(2004)Recent advances in biological therapy for inflammatory bowel disease Trop Gastroenterol. 25 9-14